Introduction {#S1}
============

Bacitracin, an important peptide antibiotic that consists of 11 kinds of amino acids, is mainly produced by *B*. *licheniformis* and *Bacillus subtilis*. Bacitracin biosynthetase gene cluster in *B. licheniformis* spans over 45 kd of DNA, which containing four genes, *bacT*, *bacA*, *bacB* and *back*. Gene *bacT* encodes thioesterase, and the relationship between bacitracin synthesis with *bacT* is unclear. BacA is responsible for activating and polymerizing five kinds of amino acids (Ile, Cys, Leu, D-Glu, and Ile) at bacitracin tail, BacB and BacC are responsible for activating and polymerizing seven kinds of amino acids in heptapeptide loop ([@B31]). Bacitracin owns the advantages of wide antimicrobial spectrum, rapid excretion rate, low absorption of livestock and poultry, not easy to produce resistance etc., and it inhibits the synthesis of cell wall of most gram-positive and a few of gram-negative bacteria, thus, bacitracin is widely used as the feed additive in feed industry, however, the low-yield has hindered its application ([@B10]).

With the development of synthetic biology and metabolic engineering, many elements and strategies have been developed for antibiotic metabolic engineering breeding ([@B43]). The Leu-responsive regulatory protein Lrp has been engineered to improve erythromycin and actinorhodin production in *Streptomyces* ([@B19]), and deletion of phosphorus metabolism regulator gene *phop* was proven to be beneficial for avermection, pimaricin, etc., production ([@B29]; [@B20]; [@B21]). In addition, precursor supply served as the critical role in secondary metabolite synthesis ([@B36]). Branched chain amino acid (BCAA) served as the critical role in erythromycin production, and strengthening BCAA supplies led to a 41% increase of erythromycin yield, via deleting *lrp* and overexpressing BCAA transporter SACE_5387 ([@B19]). Moreover, acety-CoA carboxylase was overexpressed to improve malonyl-CoA supply, which further led to a 43% increase of surfactin production, reached 13.37 g/L ([@B33]). In addition, efficient use of substrate is also critical for metabolite production. Previously, maltose ABC transporter MalEFG was strengthened to improve utilization rate of corn starch, resulting in a 3.3-fold increase of ivermectin production in *Streptomyces* ([@B17]). Generally, S-adenosylmethionine (SAM) served as the critical role in antibiotic biosynthesis, and strengthening SAM supply has been proven as an efficient strategy for lincomycin, avermectin, novobiovin, cephalosporin, etc., production ([@B42]). However, whether SAM supply affects bacitracin synthesis has not been investigated in *Bacillus*.

S-Adenosylmethionine is one of the most widely used cofactor for group transfer reactions that involved in various metabolic processes, and it serves as the main methyl donor for DNA methylation, protein and secondary metabolite syntheses ([@B26]), and SAM-dependent methylation is also the critical step for metabolite production. In addition, SAM addition improves antibiotic synthesis might via activating the transcription of pathway-specific regulatory genes or increasing the auto-phosphorylation of regulatory kinase ([@B14]). Generally, SAM is synthesized from aspartate, which generated from glucose via glycolytic and tricarboxylic acid (TCA) cycle, and methionine (Met) serves as the direct precursor for SAM biosynthesis ([@B26]). Recently, several strategies have been conducted to improve SAM production, including: (i) enhancing activity of SAM synthetase, (ii) deleting cystathionin--β-synthase, (iii) releasing the feedback inhibitions of SAM to SAM synthetase and methylenetetrahydrofolate reductase ([@B8]). In addition, SAM titer was significantly enhanced via coupling SAM synthetic pathway with TCA cycle in *Bacillus amyloliquefaciens* ([@B26]).

*Bacillus licheniformis* DW2 is an industrial strain for bacitracin production ([@B6]), and several metabolic engineering approaches have been developed to improve bacitracin production. The synthetic pathways of Lysine (Lys) and Ornithine (Orn) were strengthened, which led to 28.95 and 16.5% increases of bacitracin yields, respectively ([@B37]; [@B40]). BCAA transporters BrnQ and YdhG were engineered to improve intracellular BCAA accumulations for bacitraicn synthesis ([@B18]; [@B44]). Additionally, the main regulators in carbon, nitrogen and phosphorus metabolisms were engineered, which led to a 35.72% increase of bacitraicn yield ([@B6]). Due to the importance of SAM supply on antibiotic synthesis, in this study, we want to improve bacitracin production via rewiring SAM synthetic pathways, including in SAM synthetic, degradation and Met transportation pathways. Our results demonstrated that SAM supply served as a critical role on bacitracin synthesis, and this study provided a promising strain for industrial production of bacitracin.

Materials and Methods {#S2}
=====================

Strains, Plasmids and Cultivation Conditions {#S2.SS1}
--------------------------------------------

The strains and plasmids used in this research were listed in [Table 1](#T1){ref-type="table"}. *B. licheniformis* DW2 acted as the original strain for constructing recombinants ([@B45]), and *Escherichia coli* DH5α served as the host for vector construction. The plasmid T~2~(2)-Ori was applied for gene deletion, promoter replacement and gene integration *in B. licheniformis*, pHY300PLK was applied for constructing gene expression vector. All primers used in this research were provided in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}.

###### 

The strains and plasmids used in this research.

  Strains and plasmids           Relevant properties                                                                         Source of references
  ------------------------------ ------------------------------------------------------------------------------------------- ----------------------
  **Strains**                                                                                                                
  *Escherichia coli* DH5α        *sup*E44 Δ*lac*U169 (f 80 *lacZ*ΔM15) *hsd* R17 *recA*1 *gyr*A96 *thi*1 *rel*A1             This study
  *Bacillus licheniformis* DW2   Wide-type CCTCC M2011344                                                                    CCTCC
  DW2/pHY-metK~Bl~               DW2 harboring SAM synthetase MetK expression vector pHY-metK~Bl~                            This study
  DW2/pHY-metK~Cg~               DW2 harboring SAM synthetase MetK~Cg~ expression vector pHY-metK~Cg~                        This study
  DW2/pHY-SAM2                   DW2 harboring SAM synthetase SAM2 expression vector pHY-SAM2                                This study
  DW2/pHY-300                    DW2 harboring pHY300PLK, as the control strain                                              This study
  DW2-K                          SAM synthetase SAM2 integrated overexpression strain, based on strain DW2                   This study
  DW2-K/pHY-metH~Bl~             DW2-K harboring Met synthetase MetH expression vector pHY-metH~Bl~                          This study
  DW2-K/pHY-metH~Cg~             DW2-K harboring Met synthetase MetH expression vector pHY-metH~Cg~                          This study
  DW2-K/pHY-Met6                 DW2-K harboring Met synthetase Met6 expression vector pHY-Met6                              This study
  DW2-KE                         Met synthetase MetH overexpression strain via promoter replacement, based on strain DW2-K   This study
  DW2/pHY-metN                   DW2 harboring Met transporter MetN expression vector pHY-metN                               This study
  DW2/pHY-metP                   DW2 harboring Met transporter MetP expression vector pHY-metP                               This study
  DW2△metN                       Deletion of *metN* in DW2                                                                   This study
  DW2△metP                       Deletion of *metP* in DW2                                                                   This study
  DW2-KEN                        Deletion of *metN* in DW2-KE                                                                This study
  DW2-KENP                       Overexpression of *metP* in DW2-KEN                                                         This study
  DW2-KENP△mtnN                  Deletion of *mtnN* in DW2-KENP                                                              This study
  DW2-KENP△speD                  Deletion of *speD* in DW2-KENP                                                              This study
  DW2-KENPND                     Deletion of *mtnN* and *speD* in DW2-KENP                                                   This study
  **Plasmids**                                                                                                               
  pHY300PLK                      *E. coli* and *B. s* shuttle vector; Amp^*r*^, Tet^*r*^                                     Lab collection
  T~2~(2)-Ori                    *Bacillus* knockout vector; Kan^*r*^                                                        Lab collection
  pHY-metK~Bl~                   SAM synthetase MetK~Bl~ expression vector, based on pHY300PLK                               This study
  pHY-metK~Cg~                   SAM synthetase MetK~Cg~ expression vector, based on pHY300PLK                               This study
  pHY-SAM2                       SAM synthetase SAM2 expression vector, based on pHY300PLK                                   This study
  pHY-MetH~Bl~                   Met synthetase MetH~Bl~ expression vector, based on pHY300PLK                               This study
  pHY-metH~Cg~                   Met synthetase MetH~Cg~ expression vector, based on pHY300PLK                               This study
  pHY-Met6                       Met synthetase Met6 expression vector, based on pHY300PLK                                   This study
  pHY-metN                       Met transporter MetN expression vector, based on pHY300PLK                                  This study
  pHY-metP                       Met transporter MetP expression vector, based on pHY300PLK                                  This study
  T~2~-:SAM2                     T~2~(2)-Ori-*SAM2*(A+*SAM2*+B); to overexpress *SAM2*                                       This study
  T~2~-PbacA-PmetH               T~2~(2)-Ori-*PmetH*(A+PbacA+B); to replace the promoter of *metH* by PbacA                  This study
  T2-metN                        T~2~(2)-Ori-*metN*(A+B); to delete *metN*                                                   This study
  T2-metP                        T~2~(2)-Ori-*metP*(A+B); to delete *metP*                                                   This study
  T~2~-PbacA-PmetP               T~2~(2)-Ori-*PmetP*(A+PbacA+B); to replace the promoter of *metP* by PbacA                  This study
  T2-mtnN                        T~2~(2)-Ori-*mtnN*(A+B); to delete *mtnN*                                                   This study
  T2-speD                        T~2~(2)-Ori-*speD*(A+B); to delete *speD*                                                   This study

Luria-Bertani (LB) medium was served as the basic medium for strain cultivation, and corresponding antibiotics (20 mg/L kanamycin, 20 mg/L tetracycline or 50 mg/L ampicillin) were added when necessary. The seed culture was inoculated in a 250 mL flask containing 20 mL LB medium for 6 h, and transferred (1 mL) into bacitracin production medium (10% soybean meal, 4.5% corn starch, 0.1% (NH~4~)~2~SO~4~, 0.6% CaCO~3~, natural pH), and then cultivated at 37°C, 230 r/min for 48 h. In order to analyze the function roles of Met transporters MetN and MetP, ME medium (20 g/L glucose, 20 g/L sodium glutamate, 10 g/L sodium citrate, 7 g/L NH~4~Cl, 0.5 g/L K~2~HPO~4~ 3H~2~O, 0.5 g/L MgSO~4~ 7H~2~O, 0.04 g/L FeCl~3~*cdot*6H~2~O, 0.104 g/L MnSO~4~*cdot*H~2~O, 0.15 g/L CaCl~2~ 2H~2~O, pH 7.2) was applied ([@B2]). All the fermentation experiments were repeated at least three times.

Construction of Gene Expression Vector {#S2.SS2}
--------------------------------------

The gene expression vector was constructed according to our previous research ([@B45]), based on pHY300PLK, and SAM synthetase MetK from *B. licheniformis* expression vector pHY-metK~Bl~ was served as an example. Briefly, P43 promoter from *B. subtilis* 168, gene *metK* and *amyL* terminator from *B. licheniformis* DW2 were amplified by corresponding primers ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}), and fused by Splicing Overlap Extension (SOE)-PCR. The fused fragment was inserted into pHY300PLK at restriction sites *Eco*RI/*Xba*I, diagnostic PCR and DNA sequence confirmed that gene expression vector was constructed successfully, named as pHY-metK~Bl~. Similarly, other gene expression vectors were attained by the same method.

Gene Deletion in *B. licheniformis* {#S2.SS3}
-----------------------------------

The method for gene deletion in *B. licheniformis* was referred to our previously reported research ([@B6]), and Met transporter gene *metN* deletion strain was served as an example. In brief, the upstream and downstream homology arms of *metN* were amplified from *B. licheniformis* DW2, and fused by SOE-PCR. The fused fragment was inserted into T~2~(2)-Ori at restriction sites *Sac*I/*Xba*I, diagnostic PCR and DNA sequence confirmed that gene deletion vector was constructed successfully, named T2-metN. Then, T2-metN was transferred into *B. licheniformis* DW2 via electroporation, and the positive transformants were cultivated in LB medium with 20 mg/L kanamycin at 45°C, and sub-cultured for three generations. Then, transferred into LB medium and sub-cultured for six generations at 37°C. The gene *metN* deletion strain was attained via homologous double crossover, diagnostic PCR and DNA sequence confirmed that *metN* deletion strain was constructed successfully, named as DW2ΔmetN.

Gene Integrated Expression in *B. licheniformis* {#S2.SS4}
------------------------------------------------

To construct the strain which overexpressing SAM synthetase SAM2 from *Saccharomyces cerevisiae*, gene *SAM2* mediated by P43 promoter was integrated into the chromosome of *B. licheniformis* DW2, following to previously reported protocol ([@B3]), diagnostic PCR and DNA sequence confirmed that the gene integrated overexpression strain was constructed successfully.

Promoter Replacement in *B. licheniformis* {#S2.SS5}
------------------------------------------

The method for gene promoter replacement in *B. licheniformis* was referred to our previously reported research ([@B37]), and the procedure for promoter of Met synthetase MetH replaced by PbacA, a strong promoter that has been proven in our previous research ([@B27]), was served as an example. Briefly, the upstream and downstream homology arms of PmetH, promoter PbacA, were amplified to form T2-PbacA-PmetH, and promoter PmetH was replaced by PbacA via homologous double crossover, which procedure was the same as that of gene deletion.

Analytical Methods {#S2.SS6}
------------------

Bacitracin yield was measured by Agilent 1260 high performance liquid chromatography (HPLC), equipped with C18 column (ZORBAX SB-C18). Cell biomass was determined by dilution coating method ([@B5]). SAM concentration was determined by HPLC ([@B26]), and concentrations of intracellular and extracellular amino acids were measured by gas chromatography (GC), according to our previously reported research ([@B6]). The transcriptional levels of bacirtacin synthetase gene cluster were determined by RT-qPCR, and gene *16S rDNA* was served as the reference for data normalization ([@B4]).

Statistical Analysis {#S2.SS7}
--------------------

All data were conducted to analyze the variance at *P* \< 0.05 and *P* \< 0.01, and a *t*-test was applied to compare the mean values using the software package Statistica 6.0, and bars represented the standard deviations, ^∗^*P* \< 0.05; and ^∗∗^*P* \< 0.01 indicated the significance levels between recombinant strains and control ([@B3]).

Results {#S3}
=======

Exogenous SAM Addition Benefited Bacitracin Production {#S3.SS1}
------------------------------------------------------

Previously, SAM was proven to own the critical role in the syntheses numerous kinds of antibiotic ([@B42]), however, whether SAM supply affect bacitracin synthesis has not been clarified in *Bacillus*. Here, different concentrations of SAM was, respectively, added into bacitracin production medium at 24 h (The beginning period of bacitracin synthesis), and our results in [Figure 1A](#F1){ref-type="fig"} implied that exogenous SAM addition benefited bacitracin production, and the maximum bacitracin yield (832.45 U/mL) was attained under the condition of 40 mg/L SAM addition, increased by 12.13% compared to control (742.43 U/mL). Transcriptional levels of bacitracin synthetase genes *bacT*, *bacA*, *bacB* and *bacC* were measured under optimal condition, and our results implied that SAM addition improved transcription of bacitracin synthetase, increased by 1. 43-, 1. 34-, 1. 31-, and 1.29-fold, respectively ([Figure 1B](#F1){ref-type="fig"}). In addition, our results demonstrated that SAM addition have no effects on cell biomass ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). Moreover, the concentrations of intracellular SAM and Met were determined before (24 h) and after (36 h) SAM addition. Our results implied that the concentrations of intracellular SAM was 7.54 mg/L at 24 h, and which was increased to 17.29 mg/L at 30 h when SAM addition, increased by 53.69% compared to the control group (11.25 mg/L). While, Met concentrations showed no significant differences between two groups ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}). Taken together, these above results demonstrated that SAM served as the key role in bacitracin synthesis, and strengthening SAM supply was conducive to bacitracin production.

![Effects of exogenous SAM addition on bacitracin production. **(A)** Effects of different concentrations of SAM (20, 30, 40, 50, and 60 mg/L) additions on bacitracin yield, **(B)** Effects of SAM addition on the transcriptional levels of bacitracin synthetase genes *bacT*, *bacA*, *bacB*, and *bacC*. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 indicate the significance levels between recombinant strains and control strain.](fbioe-08-00305-g001){#F1}

Overexpressing SAM Synthetase Improved SAM Accumulation and Bacitracin Yield {#S3.SS2}
----------------------------------------------------------------------------

S-Adenosylmethionine synthetase served as the key role in SAM formation from Met and ATP ([@B13]), and overexpression of SAM synthetase benefited SAM production ([@B26]). The SAM synthetic pathway of *B. licheniformis* was showed in [Figure 2](#F2){ref-type="fig"}, here, SAM synthetases from *B. licheniformis*, *Corynebacterium glutamicum*, *S. cerevisiae* were strengthened in *B. licheniformis* DW2, attaining recombinant strains DW2/pHY-MetK~Bl~, DW2/pHY-MetK~Cg~ and DW2/pHY-SAM2, respectively.

![Metabolic engineering of SAM synthetic and degradation, Met transportation pathways for SAM accumulation and bacitracin synthesis in *B. licheniformis*.](fbioe-08-00305-g002){#F2}

Then, all these recombinant strains were cultivated in bacitracin production medium, as well as controls DW2 and DW2/pHY300. Based on our results of [Figure 3A](#F3){ref-type="fig"}, bacitracin yields produced by DW2/pHY-MetK~Bl~, DW2/pHY-MetK~Cg~ and DW2/pHY-SAM2 were 724.32 U/mL, 743.42 U/mL and 765.31 U/mL, increased by 8.40, 11.24, and 14.51% compared with that of DW2/pHY300 (668.27 U/mL). In addition, cell biomasses of these strains showed no significant differences, and bacitracin produced by per cell were 1.95^∗^10^--8^ U/CFU, 2.00^∗^10^--8^ U/CFU and 2.05 U^∗^10^--8^/CFU, 7.97%, 10.46 and 13.43% higher than that of DW2/pHY300 (1.81^∗^10^--8^ U/CFU), respectively. Furthermore, *SAM2* expression cassette was inserted into chromosome of DW2, attaining SAM2 integrated overexpression strain DW2-K. Based on the results of [Figure 3B](#F3){ref-type="fig"}, bacitracin yield of DW2-K reached 795.42 U/mL, increased by 7.14% compared to DW2 (742.43 U/mL). The bacitracin produced by per cell was 1.98^∗^10^--8^ U/CFU, increased by 6.30% (1.84^∗^10^--8^ U/CFU). The concentration of intracellular SAM (36 h) in DW2-K was 26.32 mg/L, 41.96% higher than that of DW2 (18.54 mg/L). Additionally, transcriptional levels of genes *bacT*, *bacA*, *bacB and bacC* were also increased significantly ([Figure 3C](#F3){ref-type="fig"}), as the increase of SAM accumulation in DW2-K.

![Effects of strengthening SAM synthetase expression on SAM accumulation and bacitracin production. **(A)** Effects of SAM synthetase overexpression on bacitracin yield and cell biomass, **(B)** Effects of integrated overexpression of SAM2 from *S. cerevisiae* on bacitraicn yield, cell biomass and SAM accumulation, **(C)** Effects of SAM2 overexpression on the transcriptional levels of bacitracin synthetase genes *bacT*, *bacA*, *bacB*, and *bacC*. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 indicate the significance levels between recombinant strains and control strain.](fbioe-08-00305-g003){#F3}

Strengthening Precursor Met Supply Benefited SAM Accumulation and Bacitracin Production {#S3.SS3}
---------------------------------------------------------------------------------------

Acting as the precursor for SAM synthesis, Met supply might affect the synthetic efficiency of SAM, which further affect bacitracin production. Here, Met synthetases from *B. licheniformis* (MetH), *C. glutamicum* (MetH), *S. cerevisiae* (Met6) were strengthened in DW2-K, attaining strains DW2-K/pHY-MetH~Bl~, DW2-K/pHY-MetH~Cg~ and DW2-K/pHY-Met6, respectively. Our results implied that overexpression of MetH from *B. licheniformis* benefited bacitracin synthesis, however, strengthening Met synthases from *C. glutamicum* and *S. cerevisiae* has no positive effect on bacitracin production. After that, the promoter of *metH* of DW2-K was replaced by bacitracin synthetase cluster promoter PbacA, a proven strong promoter that has been confirmed in our previous research ([@B27]), attaining MetH overexpression strain DW2-KE. Based on our results, bacitracin produced by DW2-KE reached 839.54 U/mL, increased by 5.55 and 13.08% compared to DW2-K and DW2, respectively. Bacitracin produced by per cell was 2.03^∗^10^--8^ U/mL, increased by 11.89 and 3.51% ([Figure 4A](#F4){ref-type="fig"}). In addition, the intracellular Met and SAM concentrations (36 h) were 39.54 mg/L and 31.54 mg/L, increased by 34.40 and 19.83% compared with those of DW2-K (29.42 mg/L and 26.32 mg/L), respectively ([Figure 4B](#F4){ref-type="fig"}). Taken together, all these above results demonstrated that strengthening Met synthetic pathway benefited SAM accumulation and bacitracin production.

![Effects of methionine synthetase overexpression on bacitracin production and cell biomass. **(A)** Bacitracin yield and cell biomass, **(B)** The concentrations of intracellular SAM and Met. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 indicate the significance levels between recombinant strains and control strain.](fbioe-08-00305-g004){#F4}

Identification and Engineering Met Transporters MetN and MetP Improved SAM Supply and Bacitracin Yield {#S3.SS4}
------------------------------------------------------------------------------------------------------

Apart from metabolic pathway, engineering transportation pathway is also regarded as an efficient approach to improve target metabolite production. Previously, amino acid transporters LysE, BrnFE, and TcyP have been identified and engineered for Lys, Val and Cys production ([@B7]; [@B22]; [@B9]), and deleting Lys transporter LysE and BCAA permease YhdG were also proven to be beneficial for bacitracin syntheses ([@B18]; [@B37]). Here, MetN and MetP were annotated as Met transporters in *B. licheniformis* DW2, however, transportation modules of them have not been clarified, nor their roles on bacitracin production.

To elucidate the transportation modes of these two transporters, genes *metN* and *metP* were deleted and overexpressed in DW2, attaining DW2△metN, DW2△metP, DW2/pHY-MetN and DW2/pHY-MetP, respectively. Then, these strains were cultivated in ME medium, and the concentrations of intracellular and extracellular Met were measured after 24 h cultivation. Based on the results of [Figure 5A](#F5){ref-type="fig"}, strengthening MetP expression benefited Met import, while the concentration of intracellular Met was dropped significantly in MetN overexpression strain, and vice versa. Collectively, these above results suggested that MetN and MetP might act as the Met exporter and importer in *B. licheniformis* DW2, respectively.

![Identifying and engineering Met transporters for enhancement production of bacitracin. **(A)** The extracellular and intracellular of Met in ME medium, **(B)** Effects of deletion and overexpression of *metN* and *metP* on bacitracin production and cell biomass, **(C)** The concentrations of intracellular Met and SAM, **(D)** The concentrations of extracellular Met and SAM, **(E)** Effects of *metN* deletion and *metP* overexpression on bacitracin yields and intracellular SAM concentrations. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 indicate the significance levels between recombinant strains and control strain.](fbioe-08-00305-g005){#F5}

Then, all these strains were cultivated in bacitracin production medium, and further results implied that *metN* deletion and *metP* overexpression benefited bacitracin production, which yields were increased by 9.55 and 8.05%, meanwhile, bacitracin yields were decreased by 9.58 and 27.73% in *metN* overexpression and *metP* deletion strains, compared to DW2 and DW2/pHY300, respectively ([Figure 5B](#F5){ref-type="fig"}). Moreover, the intracellular Met concentrations were increased by 24.71 and 13.71% in DW2△metN and DW2/pHY-MetP, which concentrations were dropped by 18.17 and 15.59% in DW2△metP and DW2/pHY-MetN, indicated that *metN* deletion and MetP overexpression benefited intracellular Met accumulation ([Figures 5C,D](#F5){ref-type="fig"}). Since Met served as the critical role in SAM synthesis and accumulation, the transporters MetN and MetP were confirmed to act as Met exporter and importer, respectively.

To further improve bacitracin synthesis capability of DW2-KE, gene *metN* was deleted to attain DW2-KEN, and *metP* was further overexpressed via promoter replacement, attaining strain DW2-KENP. Bacitracin fermentation results implied that 889.42 U/mL bacitracin was produced by DW2-KENP, increased by 19.80 and 5.94%, compared to DW2 and DW2-KE, and the specific bacitracin yield of DW2-KENP were increased by 20.31 and 5.71%, respectively. Meanwhile, the intracellular SAM concentration was increased to 37.98 mg/L, increased by 104.85 and 20.42%, respectively ([Figure 5E](#F5){ref-type="fig"}).

Blocking SAM Degradation Pathways Improved Bacitracin Synthesis {#S3.SS5}
---------------------------------------------------------------

In the above work, although concentration of intracellular SAM was enhanced significantly, the accumulated SAM might also be transformed into byproducts S-D-Ribosyl-L-homocysteine and S-Adenosyl-methioninamine, under the catalyses of SAM nucleosidase MtnN and SAM decarboxylase SpeD, respectively, which was not conducive to SAM accumulation. Here, genes *mtnN* and *speD* were deleted in DW2-KENP, resulting in DW2-KENP△mtnN and DW2-KENP△speD, respectively. As shown in [Figure 6](#F6){ref-type="fig"}, deletion of *mtnN* and *speD* were beneficial for intracellular SAM accumulation, and bacitracin yields were also enhanced in gene deletion strains. Furthermore, the strain DW2-KENPND was attained via deleting *mtnN* and *speD* simultaneously, and bacitracin yield of DW2-KENPND reached 957.25 U/mL, increased by 28.93 and 7.63% compared to DW2 and DW2-KENP, respectively ([Figure 6A](#F6){ref-type="fig"}). The intracellular SAM concentration of DW2-KENPND was 47.53 mg/L, increased by 1.56-fold compared to DW2 ([Figure 6B](#F6){ref-type="fig"}). In addition, the harmful by-products during bacitraicn production, cadaverine and putrescine, produced by DW2-KENPND were 53.24and 37.52 mg/L, decreased by 27.50 and 37.04% compared with those of DW2 (73.43 mg/L and 52.25 mg/L), as the weakened expression of amino acid decarboxylase ([Figure 6C](#F6){ref-type="fig"}). Moreover, the transcriptional levels of *bacT*, *bacA*, *bacB* and *bacC* were increased by 3. 63-, 3. 35-, 3. 37-, and 3.23-fold, respectively ([Figure 6D](#F6){ref-type="fig"}).

![Effects of *mtnN* and *speD* deletion on bacitraicn production. **(A)** Bacitracin yield and cell biomass, **(B)** The concentration of intracellular SAM, **(C)** The concentrations of cadaverine and putrescine, **(D)** Transcriptional level analysis. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 indicate the significance levels between recombinant strains and control strain.](fbioe-08-00305-g006){#F6}

The Fermentation Processes of *B. licheniformis* DW2 and DW2-KENPND {#S3.SS6}
-------------------------------------------------------------------

Furthermore, the fermentation curves of *B. licheniformis* DW2 and DW2-KENPND were measured, and cell biomass and bacitracin yields were determined during fermentation process. Based on the results of [Figure 7](#F7){ref-type="fig"}, bacitracin was synthesized from 12 h, and bacitracin yields of DW2-KENPND were higher than those of DW2 throughout the whole fermentation process, and the maximum yield produced by DW2-KENPND reached 957.53 U/mL, increased by 28.97%. In addition, the maximum cell biomass of DW2-KENPND was 428.54^∗^10^8^ CFU/mL, increased by 6.22% compared to DW2 (403.43^∗^10^8^ CFU/mL). The bacitracin produced by per cell was 2.23^∗^10^--8^ U/CFU, 21.42% higher than that of DW2 (1.84^∗^10^--8^U/CFU).

![The fermentation process curves of *B. licheniformis* DW2 and DW2-KENPND.](fbioe-08-00305-g007){#F7}

Discussion {#S4}
==========

Bacitracin is a widely used veterinary antibiotic that mainly produced by *Bacillus*, and low production efficiency limits its promotion and application. SAM is an important cofactor in cell metabolism, which serves as the critical roles in syntheses of multiple antibiotics ([@B42]). However, whether SAM affects antibiotic synthesis in *Bacillus*, especially for bacitracin, is still unknown. In this study, our results confirmed that strengthening intracellular SAM accumulation was beneficial for bacitracin production, and a metabolic engineered strain *B. licheniformis* DW2-KENPND with bacitracin yield of 957.53 U/mL was attained, via rewiring SAM synthetic and Met transportation pathways.

Acting as a critical methyl donor, SAM serves as the important role in the biosynthesis of multiple antibiotics ([@B41]), in addition, SAM could increase the transcription of pathway-specific regulatory genes or auto-phosphorylation of regulatory kinase ([@B1]), therefore, strengthening SAM supply has been proven to be beneficial for production of lincomycin ([@B23]; [@B38]), avermectin ([@B30]), erythromycin ([@B34]), actinorhodin ([@B14]), etc. Moreover, SAM is not only involved in the transfer of sulfenyl and ribosyl groups, but also regulates intracellular metabolites that involved in primary and second metabolisms ([@B26]). In this research, bacitracin is produced by Non-Ribosomal Polypeptide Synthetases (NRPS) in *B. licheniformis* ([@B25]), different from those of above antibiotics (Polyketide Synthase) that which were mainly produced by *Streptomyces*, moreover, our results implied that strengthening SAM supply increased the transcription of bacitracin synthetase gene cluster, and transcriptional levels of genes *bacT*, *bacA*, *bacB*, and *bacC* were enhanced all under the condition of SAM addition. In addition, the transcriptional level of regulator gene *abrB* was decreased by 32.54% ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}). Since regulator AbrB has been proven as the negative regulator of bacitracin synthetase cluster *bacTABC* ([@B31]), our results suggested that additional SAM attenuated the inhibitory effect of AbrB on bacitracin synthase, and then improved bacitracin synthesis. Nevertheless, more work needs to be done to resolve the relationship between SAM and bacitracin synthetase.

Based on the previous researches, Met yield produced by microbial is generally at a high level ([@B11]), while SAM yield is quite low ([@B8]; [@B35]), indicating the low efficiency of SAM synthetic and transportation capabilities. Here, several SAM synthetases from *B. licheniformis*, *C. glutamicum* and *S. cerevisiae* were tested, and SAM2 from *S. cerevisiae* showed the best performances on SAM accumulation and bacitracin synthesis, consistent with the previous results of our group ([@B26]). Along with developments of metabolic engineering and synthetic biology, various strategies have been conducted to improve SAM accumulation, including in strengthening SAM synthetic pathways ([@B41]), coupling with TCA cycle ([@B26]), increasing ATP level ([@B13]), etc. In this research, the SAM synthetic and degradation pathways, Met transportation pathways were engineered to improve intracellular SAM accumulation for bacitracin production, and SAM concentration was increased to 47.53 mg/L by 1.56-fold, which led to a 28.97% increase of bacitracin yield. Based on the previous researches, the corresponding SAM transporters have been identified in *E. coli*, *Streptomyces coelicolor* etc., ([@B15]; [@B39]; [@B12]), also, the intracellular SAM concentration at 30 h was increased by 53.69% after SAM addition, suggested that additional SAM could be imported by amino acid transporter, thus, we suggested that SAM transporter is also present in *B. licheniformis* DW2, although it has not been identified or annotated. In addition, SAM decarboxylase gene *speD* was deleted to block synthetic pathway of byproduct, meantime, based on our results, two other harmful by-products, cadaverine and putrescine ([@B16]), were also decreased by 27.50 and 37.04%, due to the weakening of amino acid decarboxylase ([Figure 6C](#F6){ref-type="fig"}), and this result was positively correlated with our previous research ([@B37]). Furthermore, since SAM synthetase catalyzed the formation of SAM from Met and ATP, as well as the critical role of ATP supply in physiological metabolism ([@B3]), the ATP pool of DW2-KENPND should be enhanced in our future work.

Engineering transporter has been proven as an efficiency tactic for enhancement production of metabolite. Overexpression of ABC transporter AvtAB benefited avermectin secretion, and further led to the 50% increase of avermectin production ([@B24]). Lys transporter LysE has been overexpressed to improve Lys production in *C. glutamicum* ([@B9]). However, bacitracin transporter in *Bacillus* has not been identified until now, although much work has been done on bacitracin microbial breeding and regulation ([@B10]; [@B31]; [@B28]). Here, two Met transporters MetN and MetP were screened, identified and engineered for bacitracin production at the first time. Based on our results, transporter MetN acted as Met exporter and MetP functioned as Met importer, and both of them served as the critical roles in Met distribution and bacitracin synthesis. Since soybean meal contains Met ([@B32]), overexpression of MetP improved the accumulation of intracellular Met, which further benefit bacitracin production. Meantime, several other amino acid transporters (YdhG, BrnQ, and LysE) have also been engineered for bacitracin production ([@B18]; [@B44]; [@B37]), indicated that engineering amino acid transporter was an efficient strategy for bacitraicn production. Similar to Met transportation, several other amino acids also have multiple corresponding transporters. Such as, transporters YdhG, BrnQ, YvbW, and BraB were responsible for BCAAs transportation ([@B6]), LysE, LysP and YvsH for lysine transportation ([@B37]), TcyP and YdeD for cysteine transportation ([@B22]). The synergy of multiple transporters benefited the relative stability of intracellular and extracellular amino acids.

Conclusion {#S5}
==========

S-Adenosylmethionine served as the critical role in antibiotic production, however, whether it affects bacitracin synthesis is still unknown. Here, our results confirmed that exogenous SAM addition benefited bacitracin production, and a metabolic engineered strain *B. licheniformis* DW2-KENPND was attained via rewiring SAM synthetic and degradation, Met transportation pathways. Based on our results, SAM synthetase SAM2 from *S. cerevisiae* and Met synthetase MetH from *B. licheniformis* showed the best performance on SAM accumulation and bacitracin syntheses, and Met transporters MetN and MetP were identified as Met exporter and importer in *B. licheniformis* DW2, respectively. Finally, The concentration of intracellular SAM of DW2-KENPND was 47.53 U/mL, increased by 1.56-fold compared to DW2, and bacitracin yield reached 957.53 U/mL, increased by 28.97%. Taken together, this research demonstrated that SAM served as the critical role in bacitraicn synthesis, and a promising strain *B. licheniformis* DW2-KENPND was attained for industrial production of bacitracin.
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BCAAs

:   branched chain amino acid

GC

:   gas chromatography

HPLC

:   high performance liquid chromatography

Lys

:   lysine

Met

:   methionine

NRPS

:   non-ribosomal polypeptide synthetases

Orn

:   ornithine

SAM

:   S-Adenosylmethionine.
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